BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Orsolini L, Tomasetti C, Valchera A, Vecchiotti R, Matarazzo I, Vellante F, Iasevoli F, Buonaguro EF, Fornaro M, Fiengo AL, Martinotti G, Mazza M, Perna G, Carano A, De Bartolomeis A, Di Giannantonio M, De Berardis D. An update of safety of clinically used atypical antipsychotics. Expert Opin Drug Saf 2016;15:1329-47. [PMID: 27347638 DOI: 10.1080/14740338.2016.1201475] [Cited by in Crossref: 70] [Cited by in F6Publishing: 57] [Article Influence: 11.7] [Reference Citation Analysis]
Number Citing Articles
1 Fornaro M, Fusco A, Anastasia A, Cattaneo CI, De Berardis D. Brexpiprazole for treatment-resistant major depressive disorder. Expert Opinion on Pharmacotherapy 2019;20:1925-33. [DOI: 10.1080/14656566.2019.1654457] [Cited by in Crossref: 12] [Cited by in F6Publishing: 9] [Article Influence: 4.0] [Reference Citation Analysis]
2 Piccinni C, Dondi L, Ronconi G, Calabria S, Esposito I, Pedrini A, Maggioni AP, Barbui C, Martini N. Real-world data on new users of atypical antipsychotics: characterisation, prescription patterns, healthcare costs and early cardio-metabolic occurrences from a large Italian database. Eur J Clin Pharmacol 2020;76:1301-10. [DOI: 10.1007/s00228-020-02899-9] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.5] [Reference Citation Analysis]
3 Orsolini L, Menculini G, Tempia Valenta S, Fiorani M, Rocchetti D, Salvi V, Tortorella A, Volpe U. Depressive and Anxious Temperaments as Predictors of Late Onset Bipolar Disorder? Preliminary Results of a “Real World” Exploratory Study. Front Psychiatry 2022;13:836187. [DOI: 10.3389/fpsyt.2022.836187] [Reference Citation Analysis]
4 De Berardis D, Fornaro M, Anastasia A, Vellante F, Valchera A, Cavuto M, Perna G, Di Nicola M, Serafini G, Carano A, Pompili M, Orsolini L, Tomasetti C, Di Emidio G, Martinotti G, Di Giannantonio M. When Clozapine Fails: Augmentation Strategies in the Management of Clozapine-Resistant Schizophrenia. In: Kim Y, editor. Treatment Resistance in Psychiatry. Singapore: Springer; 2019. pp. 349-67. [DOI: 10.1007/978-981-10-4358-1_23] [Cited by in Crossref: 2] [Cited by in F6Publishing: 1] [Article Influence: 0.5] [Reference Citation Analysis]
5 Fornaro M, De Berardis D, Perna G, Solmi M, Veronese N, Orsolini L, Buonaguro EF, Iasevoli F, Köhler CA, Carvalho AF, de Bartolomeis A. Lurasidone in the Treatment of Bipolar Depression: Systematic Review of Systematic Reviews. Biomed Res Int 2017;2017:3084859. [PMID: 28573138 DOI: 10.1155/2017/3084859] [Cited by in Crossref: 11] [Cited by in F6Publishing: 11] [Article Influence: 2.2] [Reference Citation Analysis]
6 Madera JJ, Such P, Zhao C, Baker RA. Symptomatic stability with aripiprazole once-monthly: efficacy analyses from acute and long-term studies. Neuropsychiatr Dis Treat 2019;15:1593-604. [PMID: 31354275 DOI: 10.2147/NDT.S198786] [Cited by in Crossref: 2] [Cited by in F6Publishing: 1] [Article Influence: 0.7] [Reference Citation Analysis]
7 Himmerich H, Hotopf M, Shetty H, Schmidt U, Treasure J, Hayes RD, Stewart R, Chang CK. Psychiatric comorbidity as a risk factor for mortality in people with anorexia nervosa. Eur Arch Psychiatry Clin Neurosci 2019;269:351-9. [PMID: 30120534 DOI: 10.1007/s00406-018-0937-8] [Cited by in Crossref: 25] [Cited by in F6Publishing: 16] [Article Influence: 6.3] [Reference Citation Analysis]
8 Jiang Y, Gaur U, Cao Z, Hou ST, Zheng W. Dopamine D1- and D2-like receptors oppositely regulate lifespan via a dietary restriction mechanism in Caenorhabditis elegans. BMC Biol 2022;20:71. [PMID: 35317792 DOI: 10.1186/s12915-022-01272-9] [Reference Citation Analysis]
9 Sparacino G, Verdolini N, Vieta E, Pacchiarotti I. Existing and emerging pharmacological approaches to the treatment of mania: A critical overview. Transl Psychiatry 2022;12. [DOI: 10.1038/s41398-022-01928-8] [Reference Citation Analysis]
10 Verhaegen AA, Van Gaal LF. Drugs Affecting Body Weight, Body Fat Distribution, and Metabolic Function-Mechanisms and Possible Therapeutic or Preventive Measures: an Update. Curr Obes Rep 2021;10:1-13. [PMID: 33400222 DOI: 10.1007/s13679-020-00419-5] [Cited by in Crossref: 4] [Cited by in F6Publishing: 5] [Article Influence: 4.0] [Reference Citation Analysis]
11 Chez M, Kile S, Lepage C, Parise C, Benabides B, Hankins A. A Randomized, Placebo-Controlled, Blinded, Crossover, Pilot Study of the Effects of Dextromethorphan/Quinidine for the Treatment of Neurobehavioral Symptoms in Adults with Autism. J Autism Dev Disord 2020;50:1532-8. [DOI: 10.1007/s10803-018-3703-x] [Cited by in Crossref: 4] [Cited by in F6Publishing: 3] [Article Influence: 1.0] [Reference Citation Analysis]
12 Lee M, Marshall D, Saddichha S. Lurasidone-Associated Neuroleptic Malignant Syndrome. J Clin Psychopharmacol 2017;37:639-40. [DOI: 10.1097/jcp.0000000000000774] [Cited by in Crossref: 4] [Article Influence: 0.8] [Reference Citation Analysis]
13 Tonin FS, Wiens A, Fernandez-Llimos F, Pontarolo R. Iloperidone in the treatment of schizophrenia: an evidence-based review of its place in therapy. Core Evid 2016;11:49-61. [PMID: 28008301 DOI: 10.2147/CE.S114094] [Cited by in Crossref: 11] [Cited by in F6Publishing: 2] [Article Influence: 1.8] [Reference Citation Analysis]
14 De Berardis D, Rapini G, Olivieri L, Di Nicola D, Tomasetti C, Valchera A, Fornaro M, Di Fabio F, Perna G, Di Nicola M, Serafini G, Carano A, Pompili M, Vellante F, Orsolini L, Martinotti G, Di Giannantonio M. Safety of antipsychotics for the treatment of schizophrenia: a focus on the adverse effects of clozapine. Ther Adv Drug Saf 2018;9:237-56. [PMID: 29796248 DOI: 10.1177/2042098618756261] [Cited by in Crossref: 65] [Cited by in F6Publishing: 49] [Article Influence: 16.3] [Reference Citation Analysis]
15 Pérez-Ros P, Martínez-Arnau FM. Delirium Assessment in Older People in Emergency Departments. A Literature Review. Diseases 2019;7:E14. [PMID: 30704024 DOI: 10.3390/diseases7010014] [Cited by in Crossref: 9] [Cited by in F6Publishing: 6] [Article Influence: 3.0] [Reference Citation Analysis]
16 Wu C, Wang Y, Yang F, Shi W, Wang Z, He L, He Y, Shen J. Synthesis and Biological Evaluation of Five-Atom-Linker-Based Arylpiperazine Derivatives with an Atypical Antipsychotic Profile. ChemMedChem 2019;14:2042-51. [PMID: 31746558 DOI: 10.1002/cmdc.201900439] [Reference Citation Analysis]
17 Yatham LN, Kennedy SH, Parikh SV, Schaffer A, Bond DJ, Frey BN, Sharma V, Goldstein BI, Rej S, Beaulieu S, Alda M, MacQueen G, Milev RV, Ravindran A, O'Donovan C, McIntosh D, Lam RW, Vazquez G, Kapczinski F, McIntyre RS, Kozicky J, Kanba S, Lafer B, Suppes T, Calabrese JR, Vieta E, Malhi G, Post RM, Berk M. Canadian Network for Mood and Anxiety Treatments (CANMAT) and International Society for Bipolar Disorders (ISBD) 2018 guidelines for the management of patients with bipolar disorder. Bipolar Disord 2018;20:97-170. [PMID: 29536616 DOI: 10.1111/bdi.12609] [Cited by in Crossref: 466] [Cited by in F6Publishing: 368] [Article Influence: 116.5] [Reference Citation Analysis]
18 Azorin JM, Simon N. Dopamine Receptor Partial Agonists for the Treatment of Bipolar Disorder. Drugs 2019;79:1657-77. [PMID: 31468317 DOI: 10.1007/s40265-019-01189-8] [Cited by in Crossref: 5] [Cited by in F6Publishing: 4] [Article Influence: 2.5] [Reference Citation Analysis]
19 London EB, Yoo JH, Fethke ED, Zimmerman-Bier B. The Safety and Effectiveness of High-Dose Propranolol as a Treatment for Challenging Behaviors in Individuals With Autism Spectrum Disorders. J Clin Psychopharmacol 2020;40:122-9. [PMID: 32134849 DOI: 10.1097/JCP.0000000000001175] [Cited by in Crossref: 5] [Cited by in F6Publishing: 3] [Article Influence: 2.5] [Reference Citation Analysis]
20 Li W, Sun F, Guo X, Hu Y, Ding S, Ding M, Song M, Shao M, Yang Y, Guo W, Zhang L, Zhang Y, Wang X, Su X, Lv L. Behavioral abnormalities and phosphorylation deficits of extracellular signal-regulated kinases 1 and 2 in rat offspring of the maternal immune activation model. Physiology & Behavior 2020;217:112805. [DOI: 10.1016/j.physbeh.2020.112805] [Cited by in Crossref: 1] [Cited by in F6Publishing: 2] [Article Influence: 0.5] [Reference Citation Analysis]
21 Rosenblat JD, Mcintyre RS. Pharmacological Approaches to Minimizing Cardiometabolic Side Effects of Mood Stabilizing Medications. Curr Treat Options Psych 2017;4:319-32. [DOI: 10.1007/s40501-017-0131-z] [Cited by in Crossref: 5] [Cited by in F6Publishing: 2] [Article Influence: 1.0] [Reference Citation Analysis]
22 Mahmood S, Hussain S, ur Rehman T, Barbui C, Kurdi AB, Godman B. Trends in the prescribing of antipsychotic medicines in Pakistan: implications for the future. Current Medical Research and Opinion 2019;35:51-61. [DOI: 10.1080/03007995.2018.1513834] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 0.8] [Reference Citation Analysis]
23 Verhaegen AA, Van Gaal LF. Drug-induced obesity and its metabolic consequences: a review with a focus on mechanisms and possible therapeutic options. J Endocrinol Invest 2017;40:1165-74. [PMID: 28660606 DOI: 10.1007/s40618-017-0719-6] [Cited by in Crossref: 28] [Cited by in F6Publishing: 19] [Article Influence: 5.6] [Reference Citation Analysis]
24 Hsu MC, Lee SC, Ouyang WC. Use of Charlson Comorbidity Index and Nomogram to Predict Mortality in Elderly Patients with Late-Life Schizophrenia. Healthcare (Basel) 2021;9:783. [PMID: 34206232 DOI: 10.3390/healthcare9070783] [Reference Citation Analysis]
25 Sultana J, Giorgianni F, Rea F, Lucenteforte E, Lombardi N, Mugelli A, Vannacci A, Liperoti R, Kirchmayer U, Vitale C, Chinellato A, Roberto G, Corrao G, Trifirò G. All-cause mortality and antipsychotic use among elderly persons with high baseline cardiovascular and cerebrovascular risk: a multi-center retrospective cohort study in Italy. Expert Opin Drug Metab Toxicol 2019;15:179-88. [PMID: 30572727 DOI: 10.1080/17425255.2019.1561860] [Cited by in Crossref: 5] [Cited by in F6Publishing: 3] [Article Influence: 1.7] [Reference Citation Analysis]
26 O' Neill E, Carolan D, Kennedy S, Barry S. Late-Onset Neutropenia in Long-Term Clozapine Use and Its Management Utilizing Prophylactic G-CSF. Case Rep Psychiatry 2021;2021:6640681. [PMID: 33575054 DOI: 10.1155/2021/6640681] [Cited by in Crossref: 1] [Article Influence: 1.0] [Reference Citation Analysis]
27 Orsolini L, De Berardis D, Volpe U. Up-to-date expert opinion on the safety of recently developed antipsychotics. Expert Opin Drug Saf 2020;19:981-98. [PMID: 32657173 DOI: 10.1080/14740338.2020.1795126] [Cited by in Crossref: 9] [Cited by in F6Publishing: 7] [Article Influence: 4.5] [Reference Citation Analysis]
28 Zhang Y, Li X, Yao X, Yang Y, Ning X, Zhao T, Xia L, Zhang Y, Zhang K, Liu H. Do Leptin Play a Role in Metabolism-Related Psychopathological Symptoms? Front Psychiatry 2021;12:710498. [PMID: 34566714 DOI: 10.3389/fpsyt.2021.710498] [Reference Citation Analysis]
29 Bruno A, Pandolfo G, Crucitti M, Troili GM, Spina E, Zoccali RA, Muscatello MRA. Red Yeast Rice (RYR) supplementation in patients treated with second-generation antipsychotics. Complement Ther Med 2018;37:167-71. [PMID: 29609929 DOI: 10.1016/j.ctim.2018.03.007] [Cited by in Crossref: 5] [Cited by in F6Publishing: 5] [Article Influence: 1.3] [Reference Citation Analysis]
30 Łukasiewicz S, Mikołajczyk A, Szczęch M, Szczepanowicz K, Warszyński P, Dziedzicka-wasylewska M. Encapsulation of clozapine into polycaprolactone nanoparticles as a promising strategy of the novel nanoformulation of the active compound. J Nanopart Res 2019;21. [DOI: 10.1007/s11051-019-4587-1] [Cited by in Crossref: 6] [Cited by in F6Publishing: 3] [Article Influence: 2.0] [Reference Citation Analysis]
31 Bába L, Gáll Z, Kolcsár M, Pap Z, Varga ZV, Kovács B, Hack B, Kun I. Effect on Body Weight and Adipose Tissue by Cariprazine: A Head-to-Head Comparison Study to Olanzapine and Aripiprazole in Rats. Sci Pharm 2020;88:50. [DOI: 10.3390/scipharm88040050] [Reference Citation Analysis]
32 Earley WR, Burgess MV, Khan B, Rekeda L, Suppes T, Tohen M, Calabrese JR. Efficacy and safety of cariprazine in bipolar I depression: A double-blind, placebo-controlled phase 3 study. Bipolar Disord 2020;22:372-84. [PMID: 31628698 DOI: 10.1111/bdi.12852] [Cited by in Crossref: 12] [Cited by in F6Publishing: 12] [Article Influence: 4.0] [Reference Citation Analysis]
33 Zhang Y, Tang Z, Ruan Y, Huang C, Wu J, Lu Z, Li W, Tang Y, Liu J, She J, Wang TT, Zhu Y, Teng ZW, Zeng Y. Prolactin and Thyroid Stimulating Hormone (TSH) Levels and Sexual Dysfunction in Patients with Schizophrenia Treated with Conventional Antipsychotic Medication: A Cross-Sectional Study. Med Sci Monit 2018;24:9136-43. [PMID: 30554232 DOI: 10.12659/MSM.913759] [Cited by in Crossref: 9] [Article Influence: 2.3] [Reference Citation Analysis]
34 Dong M, Zeng LN, Zhang Q, Yang SY, Chen LY, Najoan E, Kallivayalil RA, Viboonma K, Jamaluddin R, Javed A, Hoa DTQ, Iida H, Sim K, Swe T, He YL, Park Y, Ahmed HU, De Alwis A, Chiu HFK, Sartorius N, Tan CH, Chong MY, Shinfuku N, Lin SK, Avasthi A, Grover S, Ng CH, Ungvari GS, Xiang YT. Prescription of antipsychotic and concomitant medications for adult Asian schizophrenia patients: Findings of the 2016 Research on Asian Psychotropic Prescription Patterns (REAP) survey. Asian J Psychiatr 2019;45:74-80. [PMID: 31520884 DOI: 10.1016/j.ajp.2019.08.010] [Cited by in Crossref: 18] [Cited by in F6Publishing: 15] [Article Influence: 6.0] [Reference Citation Analysis]
35 Carton L, Bordet R, Montastruc F, Guilhaumou R. Towards personalized pharmacology: Antipsychotics and schizophrenia. Therapie 2021;76:137-47. [PMID: 33423786 DOI: 10.1016/j.therap.2020.12.010] [Reference Citation Analysis]
36 Tveito M, Smith RL, Høiseth G, Molden E. The Effect of Valproic Acid on Olanzapine Serum Concentration: A Study Including 2791 Patients Treated With Olanzapine Tablets or Long-Acting Injections. J Clin Psychopharmacol 2019;39:561-6. [PMID: 31688390 DOI: 10.1097/JCP.0000000000001126] [Cited by in Crossref: 6] [Cited by in F6Publishing: 3] [Article Influence: 3.0] [Reference Citation Analysis]
37 Fluyau D, Mitra P, Lorthe K. Antipsychotics for Amphetamine Psychosis. A Systematic Review. Front Psychiatry 2019;10:740. [PMID: 31681046 DOI: 10.3389/fpsyt.2019.00740] [Cited by in Crossref: 4] [Cited by in F6Publishing: 1] [Article Influence: 1.3] [Reference Citation Analysis]
38 Xiamuxi H, Wang Z, Li J, Wang Y, Wu C, Yang F, Jiang X, Liu Y, Zhao Q, Chen W, Zhang J, Xie Y, Hu T, Xu M, Guo S, Akber Aisa H, He Y, Shen J. Synthesis and biological investigation of tetrahydropyridopyrimidinone derivatives as potential multireceptor atypical antipsychotics. Bioorganic & Medicinal Chemistry 2017;25:4904-16. [DOI: 10.1016/j.bmc.2017.07.040] [Cited by in Crossref: 7] [Cited by in F6Publishing: 5] [Article Influence: 1.4] [Reference Citation Analysis]
39 Hollingworth SA, Winckel K, Saiepour N, Wheeler AJ, Myles N, Siskind D. Clozapine-related neutropenia, myocarditis and cardiomyopathy adverse event reports in Australia 1993-2014. Psychopharmacology (Berl). 2018;235:1915-1921. [PMID: 29589067 DOI: 10.1007/s00213-018-4881-0] [Cited by in Crossref: 10] [Cited by in F6Publishing: 10] [Article Influence: 2.5] [Reference Citation Analysis]
40 Song X, El Khoury AC, Brouillette M, Smith D, Joshi K. Treatment discontinuation of long-acting injectables or oral atypical antipsychotics among Medicaid recipients with schizophrenia. Journal of Medical Economics 2019;22:1105-12. [DOI: 10.1080/13696998.2019.1615927] [Cited by in Crossref: 6] [Cited by in F6Publishing: 4] [Article Influence: 2.0] [Reference Citation Analysis]
41 Matei VP, Purnichi T, Mihailescu A, Grigoras R. PROLACTIN LEVEL IN PATIENTS WITH FIRST EPISODE SCHIZOPHRENIA TREATED FOR ONE YEAR WITH ATYPICAL ANTIPSYCHOTICS. Acta Endocrinol (Buchar) 2018;14:483-90. [PMID: 31149301 DOI: 10.4183/aeb.2018.483] [Cited by in Crossref: 2] [Article Influence: 0.7] [Reference Citation Analysis]
42 Amodeo K, Schneider RB, Hegeman Richard I. Call to Caution with the Use of Atypical Antipsychotics for Treatment of Depression in Older Adults. Geriatrics (Basel) 2016;1:E33. [PMID: 31022826 DOI: 10.3390/geriatrics1040033] [Cited by in Crossref: 2] [Cited by in F6Publishing: 1] [Article Influence: 0.3] [Reference Citation Analysis]
43 Qian PP, Wang S, Feng KR, Ren YJ. Molecular modeling studies of 1,2,4-triazine derivatives as novel h-DAAO inhibitors by 3D-QSAR, docking and dynamics simulations. RSC Adv 2018;8:14311-27. [DOI: 10.1039/c8ra00094h] [Cited by in Crossref: 5] [Article Influence: 1.3] [Reference Citation Analysis]
44 Dennis JA, Gittner LS, Payne JD, Nugent K. Characteristics of U.S. adults taking prescription antipsychotic medications, National Health and Nutrition Examination Survey 2013-2018. BMC Psychiatry 2020;20:483. [PMID: 33004022 DOI: 10.1186/s12888-020-02895-4] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 1.0] [Reference Citation Analysis]
45 Orsolini L, Papanti GD, De Berardis D, Guirguis A, Corkery JM, Schifano F. The "Endless Trip" among the NPS Users: Psychopathology and Psychopharmacology in the Hallucinogen-Persisting Perception Disorder. A Systematic Review. Front Psychiatry 2017;8:240. [PMID: 29209235 DOI: 10.3389/fpsyt.2017.00240] [Cited by in Crossref: 25] [Cited by in F6Publishing: 21] [Article Influence: 5.0] [Reference Citation Analysis]
46 Kondej M, Stępnicki P, Kaczor AA. Multi-Target Approach for Drug Discovery against Schizophrenia. Int J Mol Sci 2018;19:E3105. [PMID: 30309037 DOI: 10.3390/ijms19103105] [Cited by in Crossref: 32] [Cited by in F6Publishing: 25] [Article Influence: 8.0] [Reference Citation Analysis]
47 Fujiyama H, Sugawara H, Kanno T, Kawahara K, Tanaka H, Fukuhara R, Boku S, Takebayashi M. Combination therapy of brexpiprazole and aripiprazole for an adolescent patient with a first episode of schizophrenia: A case report. Psychiatry Clin Neurosci 2020;74:666-7. [PMID: 32909325 DOI: 10.1111/pcn.13151] [Reference Citation Analysis]
48 Lee ES, Vidal C, Findling RL. A Focused Review on the Treatment of Pediatric Patients with Atypical Antipsychotics. Journal of Child and Adolescent Psychopharmacology 2018;28:582-605. [DOI: 10.1089/cap.2018.0037] [Cited by in Crossref: 21] [Cited by in F6Publishing: 19] [Article Influence: 5.3] [Reference Citation Analysis]
49 Nawaz R, Gul S, Amin R, Huma T, Al Mughairbi F. Overview of schizophrenia research and treatment in Pakistan. Heliyon 2020;6:e05545. [PMID: 33294688 DOI: 10.1016/j.heliyon.2020.e05545] [Reference Citation Analysis]
50 Huang J, Yu Y, Lin W, Zhang D, Deng Z, Ding Q. Olanzapine-induced peripheral eosinophilia and eosinophilic pleural effusion: A case report. Medicine (Baltimore) 2018;97:e9996. [PMID: 29443793 DOI: 10.1097/MD.0000000000009996] [Cited by in Crossref: 3] [Cited by in F6Publishing: 2] [Article Influence: 0.8] [Reference Citation Analysis]
51 Chen CC, Hsu LW, Huang KT, Goto S, Chen CL, Nakano T. Overexpression of Insig-2 inhibits atypical antipsychotic-induced adipogenic differentiation and lipid biosynthesis in adipose-derived stem cells. Sci Rep 2017;7:10901. [PMID: 28883496 DOI: 10.1038/s41598-017-11323-9] [Cited by in Crossref: 7] [Cited by in F6Publishing: 6] [Article Influence: 1.4] [Reference Citation Analysis]
52 Bartram LA, Lozano J, Coury DL. Aripiprazole for treating irritability associated with autism spectrum disorders. Expert Opinion on Pharmacotherapy 2019;20:1421-7. [DOI: 10.1080/14656566.2019.1626825] [Cited by in Crossref: 8] [Cited by in F6Publishing: 7] [Article Influence: 2.7] [Reference Citation Analysis]
53 Perna G, Cuniberti F, Daccò S, Grassi M, Caldirola D. 'Precision' or 'personalized' psychiatry: different terms - same content? Fortschr Neurol Psychiatr 2020;88:759-66. [PMID: 32838431 DOI: 10.1055/a-1211-2722] [Cited by in Crossref: 1] [Article Influence: 0.5] [Reference Citation Analysis]
54 Palmiere C, Augsburger M, Varlet V. Disturbances of glucose metabolism associated with the use of psychotropic drugs: A post-mortem evaluation. Forensic Science International 2017;274:33-7. [DOI: 10.1016/j.forsciint.2016.11.033] [Cited by in Crossref: 3] [Cited by in F6Publishing: 2] [Article Influence: 0.6] [Reference Citation Analysis]
55 Orsolini L, Vellante F, Valchera A, Fornaro M, Carano A, Pompili M, Perna G, Serafini G, Di Nicola M, Martinotti G, Di Giannantonio M, De Berardis D. Atypical Antipsychotics in Major Depressive Disorder. In: Kim Y, editor. Understanding Depression. Singapore: Springer; 2018. pp. 257-68. [DOI: 10.1007/978-981-10-6577-4_18] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.2] [Reference Citation Analysis]
56 Sanson A, Riva MA. Anti-Stress Properties of Atypical Antipsychotics. Pharmaceuticals (Basel) 2020;13:E322. [PMID: 33092112 DOI: 10.3390/ph13100322] [Cited by in Crossref: 3] [Cited by in F6Publishing: 2] [Article Influence: 1.5] [Reference Citation Analysis]
57 Gao H, Luo C, Tu SJ, Lu RP, Jiang LN, Qiao HJ, Lin Q, Li NN, Chen JH. The Effect of Yijinjing on the Cognitive Function of Patients With Chronic Schizophrenia. Front Psychiatry 2021;12:739364. [PMID: 34744830 DOI: 10.3389/fpsyt.2021.739364] [Reference Citation Analysis]
58 Wang H, Xiao L, Wang HL, Wang GH. Efficacy and safety of lurasidone versus placebo as adjunctive to mood stabilizers in bipolar I depression: A meta-analysis. J Affect Disord 2020;264:227-33. [PMID: 32056755 DOI: 10.1016/j.jad.2019.11.031] [Cited by in Crossref: 2] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
59 Woo YS, Bahk WM, Lee JG, Jeong JH, Kim MD, Sohn I, Shim SH, Jon DI, Seo JS, Min KJ, Kim W, Song HR, Yoon BH. Korean Medication Algorithm Project for Bipolar Disorder 2018 (KMAP-BP 2018): Fourth Revision. Clin Psychopharmacol Neurosci 2018;16:434-48. [PMID: 30466216 DOI: 10.9758/cpn.2018.16.4.434] [Cited by in Crossref: 14] [Cited by in F6Publishing: 12] [Article Influence: 3.5] [Reference Citation Analysis]
60 Jeon SW, Kim YK. Unresolved Issues for Utilization of Atypical Antipsychotics in Schizophrenia: Antipsychotic Polypharmacy and Metabolic Syndrome. Int J Mol Sci 2017;18:E2174. [PMID: 29057817 DOI: 10.3390/ijms18102174] [Cited by in Crossref: 36] [Cited by in F6Publishing: 32] [Article Influence: 7.2] [Reference Citation Analysis]
61 Van Bulck M, Sierra-Magro A, Alarcon-Gil J, Perez-Castillo A, Morales-Garcia JA. Novel Approaches for the Treatment of Alzheimer's and Parkinson's Disease. Int J Mol Sci 2019;20:E719. [PMID: 30743990 DOI: 10.3390/ijms20030719] [Cited by in Crossref: 51] [Cited by in F6Publishing: 42] [Article Influence: 17.0] [Reference Citation Analysis]
62 Hsu HF, Kao CC, Lu T, Ying JC, Lee SY. Differences in the Effectiveness of Long-Acting Injection and Orally Administered Antipsychotics in Reducing Rehospitalization among Patients with Schizophrenia Receiving Home Care Services. J Clin Med 2019;8:E823. [PMID: 31181830 DOI: 10.3390/jcm8060823] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.3] [Reference Citation Analysis]
63 Eriksson R, Broberg BV, Ishøy PL, Bak N, Andersen UB, Jørgensen NR, Knop FK, Ebdrup BH. Bone Status in Obese, Non-diabetic, Antipsychotic-Treated Patients, and Effects of the Glucagon-Like Peptide-1 Receptor Agonist Exenatide on Bone Turnover Markers and Bone Mineral Density. Front Psychiatry 2018;9:781. [PMID: 30745885 DOI: 10.3389/fpsyt.2018.00781] [Cited by in Crossref: 5] [Cited by in F6Publishing: 5] [Article Influence: 1.7] [Reference Citation Analysis]
64 Zareifopoulos N, Panayiotakopoulos G. Treatment Options for Acute Agitation in Psychiatric Patients: Theoretical and Empirical Evidence. Cureus 2019;11:e6152. [PMID: 31890361 DOI: 10.7759/cureus.6152] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 0.7] [Reference Citation Analysis]
65 Liu Y, Li XJ, Liang Y, Kang Y. Pharmacological Prevention of Postoperative Delirium: A Systematic Review and Meta-Analysis of Randomized Controlled Trials. Evid Based Complement Alternat Med 2019;2019:9607129. [PMID: 31001357 DOI: 10.1155/2019/9607129] [Cited by in Crossref: 7] [Cited by in F6Publishing: 5] [Article Influence: 2.3] [Reference Citation Analysis]
66 Khalid M, Jegede O, Gayam V, Yang YC, Shrestha B, Mandal A, Mukhtar O, Garlapati P, Khalid M, Dufresne A. Clozapine-Induced Cardiotoxicity Presenting as Sepsis: A Case Report and Literature Review. Case Rep Med 2019;2019:3435108. [PMID: 31049067 DOI: 10.1155/2019/3435108] [Cited by in Crossref: 2] [Cited by in F6Publishing: 1] [Article Influence: 0.7] [Reference Citation Analysis]
67 Li P, Wang Y, Liu X, Zhou Z, Wang J, Zhou H, Zheng L, Yang L. Atypical antipsychotics induce human osteoblasts apoptosis via Wnt/β-catenin signaling. BMC Pharmacol Toxicol 2019;20:10. [PMID: 30755277 DOI: 10.1186/s40360-019-0287-9] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 1.0] [Reference Citation Analysis]
68 Verdolini N, Hidalgo-Mazzei D, Del Matto L, Muscas M, Pacchiarotti I, Murru A, Samalin L, Aedo A, Tohen M, Grunze H, Young AH, Carvalho AF, Vieta E. Long-term treatment of bipolar disorder type I: A systematic and critical review of clinical guidelines with derived practice algorithms. Bipolar Disord 2021;23:324-40. [PMID: 33354842 DOI: 10.1111/bdi.13040] [Reference Citation Analysis]
69 Orsolini L, Sceusa F, Pompili S, Mauro A, Salvi V, Volpe U. Severe and persistent mental illness (SPMI) in pregnancy and breastfeeding: focus on second-generation long acting injectable antipsychotics. Expert Opin Drug Saf 2021;:1-18. [PMID: 33966552 DOI: 10.1080/14740338.2021.1928634] [Reference Citation Analysis]